SEC Form 4 · accession 0001235802-15-000061
COGENTIX MEDICAL INC /DE/ · CGNT
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Robert Kill
Officer — Chairman, President & CEO · Director
Period of report
Apr 27, 2015
Accepted (ET)
Apr 29, 2015 · 4:16 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000894237
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1,F2 | Apr 27, 2015 | A | 200,000 | $0.00 | A | 301,725 | D | |
| Common Stock | holding | — | — | — | 313,658 | I | By Trust |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F3 | $1.64 | Apr 27, 2015 | A | 200,000 | A | — | Apr 26, 2022 | Common Stock | 200,000 | 200,000 | D |
Explanation of responses
- F1These shares will be issued over time upon vesting pursuant to a restricted stock grant.
- F2Includes 267,816 shares that will be issued over time upon vesting pursuant to restricted stock grants.
- F3This option vests in three almost equal annual installments beginning on April 27, 2016.